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Cysteine sulfenic acid (Cys-SOH) is an elusive intermediate in reactive oxygen species-induced
oxidation reactions of many proteins such as peroxiredoxins and tyrosine phosphatases.
Cys-SOH is proposed to play a vital role in catalytic and signaling functions. The formation of
cysteine sulfinic acid (Cys-SO2H) and cysteine sulfonic acid (Cys-SO3H) has been implicated
in the activation of matrix metalloproteinase-7 (MMP-7) and oxidation of thiol to cysteine
sulfinic acid has been associated with the autolytic cleavage of MMP-7. We have examined
the formation of cysteine sulfenic acid in a synthetic peptide PRCGVPDVA, which is a cysteine
switch domain of MMP-7 and other matrix metalloproteases. We have prepared the cysteine
sulfenic acid containing peptide, PRC(SOH)GVPDVA, by reaction with hydroxyl radicals
generated by the Fenton reaction (Fe2/H2O2). We characterized this modified peptide
by tandem mass spectrometry and accurate mass measurement experiments. In addition, we
used 7-chloro-4-nitrobenzo-2-oxa-1,3-diazol (NBD-Cl) reagent to form an adduct with PRC
(SOH)GVPDVA to provide additional evidence for the viability of PRC(SOH)GVPDVA in
solution. We also characterized an intramolecular cysteine sulfinamide cross-link product
PRC[S(O)N]GVPDVA based on tandem mass spectrometry and accurate mass measurement
experiments. These results contribute to the understanding of a proteolytic cleavage mecha-
nism that is traditionally associated with MMP activation. (J Am Soc Mass Spectrom 2007, 18,
1544–1551) © 2007 American Society for Mass SpectrometryCysteine sulfenic acid (Cys-SOH) formation playsa vital role in regulating the catalysis, functionand redox signaling of several proteins such as
peroxiredoxins, phosphatases, transcription factors,
and members of the NAD(P)H/disulfide reductase
family [1–5]. Cysteine sulfenic acids in proteins are also
widespread posttranslational modifications that can
result from oxidative stress conditions [6]. Cysteine
residues that possess a low pKa in proteins can be
selectively oxidized by reactive oxygen species (H2O2,
alkyl hydroperoxides, peroxy nitrite, hypochlorous
acid) to cysteine sulfenic acid via a cysteine thiolate
anion (Cys-S) intermediate [7–10]. Since cysteine
sulfenic acid is a highly reactive intermediate, it further
reacts with any accessible thiol to form a disulfide or
rapidly undergoes further oxidation with oxidants such
as H2O2 to give cysteine sulfinic acid (Cys-SO2H) and
cysteine sulfonic acid (Cys-SO3H) [2].
Cysteine sulfenic acid has been identified by X-ray
crystallography and 13C-NMR techniques in the active
site of the NADH peroxidase protein from Enterococcus
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doi:10.1016/j.jasms.2007.05.013faecalis [11, 12]. However, cysteine sulfenic acid was not
observed in solution in the case of PTP1-B [3] although
it was characterized in the crystal form of this protein
[13]. Because of the high reactivity of cysteine sulfenic
acid due to unfavorable solvent interactions and local
environment of most proteins [2], its definitive identi-
fication became possible only after trapping with chem-
ical reagents such as dimedone [14], a fluorophore-
containing analog of dimedone [15], NBD-Cl [16], and
recent labeling experiments with biotin-maleimide after
arsenite specific reduction [6] followed by mass spec-
trometry. Fuangthong and Helmann [17] observed a
mass increase consistent with cysteine sulfenic acid in
intact OhrR repressor protein by ESI-MS using NBD-Cl
trapping experiments. However, to the best of our
knowledge, there is no report in the literature describ-
ing the characterization of underivatized cysteine
sulfenic acid at the peptide level by tandem mass
spectrometry experiments, which are very important
for ruling out possible oxidative modifications of other
amino acids such as methionine and phenylalanine.
Macrophage-derived matrix metalloproteinases
(MMPs) are a family of zinc and calcium dependent
enzymes implicated in regulating matrix degradation in
inflammation, arthritis, cancer, cardiovascular and neu-
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domain called the cysteine switch (amino acid sequence
PRCXXPD) is proposed to regulate the activity of all
MMPs except for MMP-23 [19, 22, 23]. Likewise, MMP-7
also contains another cysteine switch sequence,
PRCGVPDVA, in its pro-domain. Fu et al. demon-
strated that pro-MMP-7 can be activated by HOCl
oxidation, but not H2O2 oxidation, converting cysteine
to cysteine sulfinic acid and cysteine sulfonic acid [24].
Thus oxygenation of thiol residue in the cysteine switch
peptide PRCGVPDVA was found to be a key event in
the autolytic cleavage of pro-MMP-7. However, these
authors did not investigate the formation of a cysteine
sulfenic acid intermediate that could be involved in the
activation mechanism of MMP-7. This prompted us to
investigate cysteine sulfenic acid formation in the cys-
teine switch sequence PRCGVPDVA of MMPs.
In this study, we have used Fenton reagents (Fe2/
H2O2) to produce highly reactive hydroxyl radicals
(OH·) that can react with the sulfhydryl group in
cysteine to give a variety of oxidation products. The
formation of hydroxyl radicals in the Fenton reaction
has been shown to be potentially more damaging to
cells than other reactive oxidants [25]. In fact, recently
we have prepared cysteine sulfinic acid and cysteine
sulfonic acid in PRCGVPDVA by hydroxyl radicals
generated in the Fenton reaction and studied their
fragmentation mechanism by ion trap tandem mass
spectrometry [26]. Here we report the preparation and
characterization by HPLC, tandem mass spectrometry
and accurate mass measurement of a stable cysteine
sulfenic acid in a synthetic peptide, PRC(SOH)GVP-
DVA that mimics the cysteine switch sequence of
MMPs.
Experimental
The peptide PRCGVPDVA was a gift by Professor
Yinsheng Wang, University of California at Riverside,
Riverside, CA. NBD-Cl was purchased from Aldrich.
PRCGVPDVA was oxidized using Fenton reagents
(Fe2/H2O2) as reported previously [26]. Briefly, 1 mM
peptide solution was incubated at 37 °C in the presence
of 0.5 mM FeSO4 and 0.2 mM H2O2 for 30 min. The
reaction was terminated by adding aliquots of methio-
nine solution until its concentration reached 1 mM.
Based on the number of counts in the extracted ion
chromatograms (Figure 1), cysteine sulfonic acid was
found to be the major product followed by cysteine
sulfinic acid, cysteine sulfenic acid and cysteine sulfin-
amide (-C[S{O}N]-) products. Adducts of PRCGVPDVA
and cysteine sulfenic acid with NBD-Cl were synthe-
sized according to Ellis et al. [16] except that we carried
out the reaction under aerobic conditions. We did not
rigorously optimize the reaction conditions to in-
crease the yield of cysteine sulfenic acid and cysteine
sulfinamide products or the adducts of PRC(S-
NBD)GVPDVA and PRC[S(O)-NBD]GVPDVA.Data-dependent nano-LC-MS/MS experiments werecarried out using a Waters CapLC (Milford, MA) cou-
pled directly to a Waters Q-TOF Micromass spectrom-
eter (Milford, MA) through a Picotip needle (New
Objective, Woburn, MA) and a home-made pre-column
flow splitter. The analytical column was a 75 m I.D. 
15 cm PepMap C18 (LC Packings, Sunnyvale, CA).
Mobile phase A was 2% acetonitrile/0.1% formic acid,
and mobile phase B was 90% acetonitrile/0.1% formic
acid in water. The gradient was 5% to 90% B over 45
min with a flow rate of 400 nL/min. Automatic switch-
ing between MS and MS/MS modes was controlled by
MassLynx 4.0 (Micromass) software, dependent on both
signal intensity and charge states from MS to MS/MS
and on either signal intensity or time from MS/MS to
MS. In the case of direct infusion MS/MS experiments,
50% acetonitrile in 0.1% formic acid was used as the
carrier and electrospray solvent at a flow rate of 500
nL/min. A 1 L aliquot of 2 M peptide solution was
injected via a divert-valve in each run under following
source conditions: spray voltage 1500 to 1800 V, cone
voltage 40 V, source temperature 80 °C. Argon was
used as a collision gas for all MS/MS experiments. The
quadrupole mass filter before the TOF analyzer was set
with LM and HM resolution of 14.0 (arbitrary units),
which is equivalent to a 1.0-Da mass window for
Figure 1. Extracted ion chromatograms of major cysteine oxida-
tion products of the cysteine switch domain peptide PRCGVPDVA
from MMP-7.transmission of precursor ions. Each spectrum was
1546 SHETTY ET AL. J Am Soc Mass Spectrom 2007, 18, 1544–1551obtained by averaging 25 scans, and the scan time
was 1 s/scan. The Q-TOF Micro instrument was
calibrated with [Glu1]-fibrinopeptide B and the data
in both MS and MS/MS modes were acquired at 5000
resolution. In the case of accurate mass measurement
experiments, the precursor ion was used as a lock mass
to calibrate the masses of the fragment ions. To assess
stability of the oxidized peptide forms, 5 L of a single
sample stored at 4 °C was injected every two hours after
quenching the Fenton reaction onto a Symmetry 5 m
particle, 180 m  20 mm C18 pre-column (Waters,
Milford, MA), then washed 5 min with 1% acetonitrile
in 0.1% formic acid at a flow rate of 20 L/min. After
washing, peptides were eluted and passed through an
Atlantis 3 m particle, 75 m  100 mm C18 analytical
column (Waters) with a gradient of 1% to 80% acetoni-
trile in 0.1% formic acid. The gradient was delivered
over 60 min by a nano-ACQUITY UPLC (Waters) at a
flow rate of 250 nL/min to a fused silica distal end-Figure 2. Partial mass spectra of major cysteine oxcoated tip nano-electrospray needle (New Objective,
Woburn, MA). MS survey scans were collected on a
Q-TOF Premiere (Waters/Micromass, Milford, MA).
Extracted ion chromatograms were generated for the
m/z of interest (927.4, 929.4, 945.4, 961.4) and an equal
number of scans were summed across the signal peak
for each corresponding time point. Normalized intensi-
ties were calculated by dividing reaction products ion
counts by those of an internal standard ([Glu1]-fibrino-
peptide B, 2 m/z 785.8). Values for two replicate
experiments were averaged and standard deviations
calculated.
Results and Discussion
Our goal was to separate and identify by nano-LC-
MS/MS all the cysteine oxidation products formed in
the hydroxyl radical reaction. The oxidation reaction
mixture including the PRCGVPDVA peptide was ana-idation products of the PRCGVPDVA peptide.
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ment with the emphasis on the identification of the
cysteine sulfenic acid product. Figure 1 shows the
extracted ion chromatograms (XIC) of possible products
that resulted from the Fenton oxidation reaction and
their masses are shown in their respective mass spectra
(Figure 2). The products at m/z 927.4, 929.4, 945.4, and
961.4 in Figure 2 differed by 14, 16, 32, and 48 Da,
respectively, from the unmodified precursor peptide
PRCGVPDVA (m/z 913.5). The latter two products, m/z
945.5 (36 Da) and m/z 961.4 (48 Da) were character-
ized as cysteine sulfinic acid and cysteine sulfonic acid,
respectively, as reported previously by us [26]. How-
ever, we could not obtain sequence information for the
products of m/z 929.5 (1)/m/z 465.2 (2) or m/z 927.5
(1)/m/z 464.2 (2) in our on-line LC-MS/MS experi-
ments. Therefore, we carried out direct infusion
MS/MS experiments for the singly charged ions of all
modified peptides including the ion of m/z 929.5, for
Figure 3. MS/MS spectra of the precursor pe
switch peptide PRCGVPDVA (m/z 913.4) and (b
(m/z 929.4).which a precursor selection window of only 1 Da wasused to avoid fragmenting impurities from adjacent
peaks.
Characterization of Cysteine Sulfenic Acid
[PRC(SOH)GVPDVA]
The MS/MS spectra of unmodified PRCGVPDVA (m/z
913.5) and the modified product at m/z 929.5 are shown
in Figure 3. In Figure 3b, the formation of the y4 (m/z
401) and b2 (m/z 254) ions rules out the possibility of
modification of either of the two prolines or the arginine
in PRCGVPDVA. However, the formation of the ion at
m/z 741 (b7  16 Da) indicates that cysteine is most
likely modified. In addition to this, the formation of the
diagnostic ion at m/z 879 (H2SO) and the loss of
neutral H2SO from b3, b4, and b7 ions confirm that the
cysteine is modified with an oxygen atom to cysteine
sulfenic acid, PRC(SOH)GVPDVA. This m/z 879 ion and
s shown in Figure 2: (a) unmodified cysteine
teine sulfenic acid product PRC(SOH)GVPDVAptide
) cysan ion at m/z 691, both due to loss of H2S from the
92
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spectrum of PRCGVPDVA (Figure 3a). Furthermore,
we observed that the MS/MS spectra of higher oxida-
tion products, cysteine sulfinic acid and cysteine sul-
fonic acid also exhibit similar neutral losses from pre-
cursor ions as well as fragment ions (data not shown).
In fact, the facile loss of neutral H2SO3 from both parent
and fragment ions is well documented in the literature
[26, 27–29]. The structural assignments for (MH)
ions at m/z 929.4, 927.4 and 913.4 in the MS spectrum
(Table 1) and for some of the key fragment ions formed
in their MS/MS spectra are further supported by the
results of high-resolution MS/MS experiments (Tables
2 and 3). We have observed that the formation of strong
b3 and y6 ions due to preferential cleavage c-terminal to
the oxidized cysteine occurs only in the cysteine sulfinic
acid but not other oxidized forms. This is due to the
formation of stable cyclic CID fragmentation products
from the cysteine sulfinic acid form in an energetically
favorable cleavage pathway similar to those formed
C-terminal to aspartic acid residues (Figure 3 and
reference [26]). In cases where observed m/z values
differ by more than 5 ppm from predicted values, this
was due to low intensity ion signals for the CID
fragment ions derived from the low abundance oxida-
tion products.
In addition to the above experimental evidence
demonstrating that a stable cysteine sulfenic acid
[PRC(SOH)GVPDVA] was produced in solution, we
further supported this finding by forming the adduct
of cysteine sulfenic acid with NBD-Cl [16]. The
MS/MS spectra of NBD adducts of PRCGVPDVA and
PRC(SOH)GVPDVA are shown in Figure 4. The spec-
trum in Figure 4b clearly showed a mass shift for the b7
(m/z 904) ion due to the cysteine sulfenic acid adduct
with NBD. In addition, a diagnostic ion at m/z 879
[-NBD-S(O)H] indicated the formation of a PRC[S(O)-
NBD]GVPDVA adduct and confirmed the viability
Table 2. High resolution data for fragment ions in the MS/MS
spectrum of (M  H) ions of PRCGVPDVA
Ion
Meas’d
mass
Calc
mass PPM Formula
(M  H) 913.4565 913.4565 0.0 C38 H65 N12 O12 S
H2 S 879.4518 879.4688 19.4 C38 H63 N12 O12
b7 725.3406 725.3405 0.2 C30 H49N10 O9 S
b5-NH3 496.2332 496.2342 2.0 C21 H34 N7 O5 S
a5 485.2651 485.2658 1.5 C20 H37 N8 O4 S
a5-NH3 468.2420 468.2393 5.8 C20 H34 N7 O4 S
b3-NH3 340.1415 340.1443 8.3 C14 H22 N5 O3 S
Table 1. High resolution data for the (M  H) ions of PRCGV
Parent ion (M  H) Meas’d mass
PRCGVPDVA 913.4565
PRC[S(O)N]GVPDVA 927.4390
PRC(SOH)GVPDVA 929.4442a3-NH3 312.1568 312.1494 23.6 C13 H22 N5 O2 Sof PRC(SOH)GVPDVA in solution. Thus both PRC
(SOH)GVPDVA and PRC[S(O)-NBD]GVPDVA under-
went very similar fragmentation pathways under these
experimental conditions.
The formation of stable cysteine sulfenic acid in
PRC(SOH)GVPDVA is also in agreement with the re-
ported reactivity order of all 20 amino acids towards
hydroxyl radicals generated in radiolysis experiments
[30] where cysteine was shown to be the most highly
reactive amino acid residue. According to rules for the
stabilization of cysteine sulfenic acid in solution [2],
hydrogen bonding is one of the main factors that can
influence the stability of cysteine sulfenic acid in pro-
teins in addition to the absence of proximal Cys-SH and
limited nonpolar solvent access. We propose a hydro-
gen bonding effect in the formation of stable cysteine
sulfenic acid in PRC(SOH)GVPDVA due to the forma-
tion of a strong intramolecular hydrogen bond between
the cysteine-SOH group and the guanidine group of
arginine (Scheme 1).
We performed a time course experiment to demon-
strate the stability of the cysteine sulfenic acid peptide
after quenching the Fenton reaction. Within experimen-
tal error, we found no detectable loss of the sulfenic acid
form after 25 h (Figure 5).
Characterization of Cysteine Sulfinamide
Cross-Link (PRC[S{O}N]GVPDVA)
To characterize the structure of the modified product
at m/z 927.5 (Figure 1d), its MS/MS spectrum was
acquired as shown in Figure 6. The formation of the
ion at m/z 401.5 (y4) eliminates the possibility of
modification at the C-terminal P, D, V, A residues.
The formation of ions at m/z 739.4 (b7  14 Da) and
m/z 482.2 (a5NH3  14 Da) suggested that the
modification could be on the C, G, or V residues.
However, the presence of low abundance diagnostic
ions at m/z 879.5 (SO) and m/z 865.5 (CH2SO),
Table 3. High resolution data for fragment ions in the MS/MS
spectrum of (M  H) ions of PRC(SOH)GVPDVA
Ion
Meas’d
mass
Calc
mass PPM Formula
(M  H) 929.4515 929.4515 0.0 C38 H65 N12 O13 S
H2O 911.4355 911.4409 5.9 C38 H63 N12 O12 S
H2SO 879.4837 879.4688 16.9 C38 H63 N12 O12
b7 741.3430 741.3354 10.3 C30 H49 N10 O10 S
b7-H2SO 691.3450 691.3527 11.2 C30 H47 N10 O9
y4 401.2066 401.2036 7.4 C17 H29 N4 O7
A, PRC[S(O)N]GVPDVA and PRC(SOH)GVPDVA
lc mass PPM Formula
3.4566 0.1 C38 H65 N12 O12 S
7.4358 3.5 C38 H63 N12 O13 S
9.4515 7.8 C38 H65 N12 O13 SPDV
Ca
91
92b4-H2SO 380.2084 380.2046 9.9 C16 H26 N7 O4
1549J Am Soc Mass Spectrom 2007, 18, 1544–1551 TANDEM MS OF CYSTEINE SULFENIC ACID IN MMP-7suggested that cysteine is modified by gain of one
oxygen and loss of two hydrogens. Thus, in addition
to the cysteine, R or G may also be involved in the
modification to account for the 14 Da increment from
the unmodified PRCGVPDVA peptide. These obser-
vations strongly suggest that the cysteine residue of
PRCGVPDVA is oxidized to form an intramolecular
cysteine sulfinamide cross-link (PRC[S{O}N]GVPDVA)
Figure 4. MS/MS spectra of (a) PRC(S-NBD)GV
Table 4. High resolution data for fragment ions in the MS/MS
spectrum of (M  H) ions of PRC[S(O)N]GVPDVA
Ion
Meas’d
mass
Calc
mass PPM Formula
(M  H) 927.4358 927.4358 0.0 C38 H63 N12 O13 S
SO 879.4617 879.4688 8.1 C38 H63 N12 O12
CH2SO 865.4400 865.4532 15.2 C37 H61 N12 O12
b7 739.3200 739.3197 0.4 C30 H47 N10 O10 S
a5-NH3 482.2100 482.2186 17.8 C20 H32 N7 O5 S
y4 401.2066 401.2036 9.0 C17 H29 N4 O7
b3-SO 323.1865 323.1832 10.3 C14 H23 N6 O3(m/z 1092.5).and that the cross-link involves the guanidine group
of the arginine residue as reported previously in
PFRCG and PFKCG peptides [31]. The high-resolu-
tion data obtained for some of these informative
fragment ions (Table 4) further supported the forma-
tion of a cysteine sulfinamide cross-link product. The
ion at m/z 254 may be formed by a rearrangement
A (m/z 1076.5) and (b) PRC[S(O)-NBD]VPDVA
Scheme 1PDV
.4) p
1550 SHETTY ET AL. J Am Soc Mass Spectrom 2007, 18, 1544–1551reaction. This type of rearrangement ion (m/z 373, b3)
was observed in the MS/MS spectra of cysteine
sulfonamide, cysteine sulfinamide, and cysteine
sulfenamide products that were formed in the oxida-
tion of PFKCG by HOCl [31].
Figure 5. The stability of reaction products at m
monitored over a period of 25 h. Samples were
quenching the Fenton reaction. The relative ion
accurate mass and elution time, normalized to
charged peptide, m/z 785.8), and values from tw
(*) was acquired once. The inset shows an expa
cross-link (927.4), and cysteine sulfenic acid (929Figure 6. MS/MS spectrum of PRCPossible Role for Cysteine Sulfenic Acid Formation
in MMP Activation
The activation mechanism of MMPs is believed to
involve the disruption of a bond between the thiol
7.4 (), 929.4 (□), 945.4 ( ), and 961.4 ( ) was
yzed via LC-MS approximately every 2 h after
t for each product was calculated according to
ternal control ([Glu1]-fibrinopeptide B doubly
eriments were averaged. The 30 min time point
scale of the key products cysteine sulfinamide
eptides./z 92
anal
coun
an in
o exp
nded[S(O)NH]GVPDVA (m/z 927.4).
1551J Am Soc Mass Spectrom 2007, 18, 1544–1551 TANDEM MS OF CYSTEINE SULFENIC ACID IN MMP-7residue of the pro-domain and a catalytic Zn atom [22].
For example, in MMP-7 the oxygenation of thiol by
HOCl disrupts the thiol-Zinc bond and leads to confor-
mational changes that allow autolytic cleavage and
access to the enzyme active site. Cysteine sulfenic acid
is a central reactive intermediate in many cellular
oxidative reaction pathways including the pathway in
which cysteine sulfinic acid and cysteine sulfonic acid
can be produced [1–5]. The cysteine sulfinamide char-
acterized in this study and as identified previously in
the synthetic peptides PFKCG and PFRCG [31] and
S100A8 protein [32], seems to be a common product in
the oxidation reactions of cysteine containing peptides
and proteins. Interestingly, in the case of S100A8 pro-
tein [32], a cysteine sulfenic acid intermediate was
proposed to be involved in the mechanism of cysteine
sulfinamide formation. Since we also identified both
cysteine sulfenic acid and cysteine sulfinamide cross link
products in the cysteine switch peptide PRCGVPDVA, we
believe that PRC(SOH)GVPDVA is a key intermediate in
the oxidation reactions of MMP-7 that could further react
with reactive oxygen species to form cysteine sulfinic acid
and cysteine sulfonic acid [33] or gives rise to novel
oxidation products like cysteine sulfinamide cross-link
with the loss of a hydrogen molecule [32].
Conclusions
We used an oxidation reaction by hydroxyl radicals gen-
erated in the Fenton reaction to generate for the first time
a stable cysteine sulfenic acid, [PRC(SOH)GVPDVA], in a
synthetic cysteine switch peptide of the matrix metallo-
proteinase MMP-7. We used tandem mass spectrometry
to characterize the structure of the cysteine sulfenic acid
as well as an intramolecular cysteine sulfinamide cross-
link product, PRC[S(O)N]GVPDVA, in solution. Our
results suggest that cysteine sulfenic acid may be in-
volved in regulating the activation of MMPs that con-
tain the cysteine switch sequence.
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